Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations
Tóm tắt
Từ khóa
Tài liệu tham khảo
Herholz, 1992, FDG transport and phosphorylation in human gliomas measured with dynamic PET, J. Neurooncol., 12, 159, 10.1007/BF00172667
Wahl, 1993, Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography, J. Clin. Oncol., 11, 2101, 10.1200/JCO.1993.11.11.2101
Brown, 1993, Overexpression of Glut-1 glucose transporter in human breast cancer. An immunohistochemical study, Cancer, 72, 2979, 10.1002/1097-0142(19931115)72:10<2979::AID-CNCR2820721020>3.0.CO;2-X
Brown, 1996, Intratumoural distribution of tritiated-FDG in breast carcinoma, J. Nucl. Med., 37, 1042
Minn, 1988, Fluorodeoxyglucose imaging, Cancer, 61, 1776, 10.1002/1097-0142(19880501)61:9<1776::AID-CNCR2820610909>3.0.CO;2-7
Okada, 1992, Positron emission tomography using fluorine-18-fluorodeoxyglucose in malignant lymphoma, J. Nucl. Med., 33, 325
Higashi, 1993, Does FDG uptake measure proliferative activity of human cancer cells? In vitro comparison with DNA flow cytometry and tritiated thymidine uptake, J. Nucl. Med., 34, 414
Herholz, 1993, Correlation of glucose consumption and tumour cell density in astrocytomas. A stereotactic PET study, J. Neurosurg., 79, 853, 10.3171/jns.1993.79.6.0853
Price, 1995, Can positron emission tomography (PET) be used to detect subclinical response to cancer therapy? The EC PET Oncology Concerted Action and the EORTC PET study group, Eur. J. Cancer., 31A, 1924, 10.1016/0959-8049(95)00421-1
Woodward, 1975, Expression of tissue isotope distribution, J. Nucl. Med., 16, 958
Zasadny, 1993, Standardised uptake values of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-d-glucose, Radiology, 189, 847, 10.1148/radiology.189.3.8234714
Kim, 1996, Dependency of standardised uptake values of fluorine-18 fluorodeoxyglucose on body size, Nucl. Med. Commun., 17, 890, 10.1097/00006231-199610000-00011
Hamberg, 1994, The dose uptake ratio as an index of glucose metabolism, J. Nucl. Med., 35, 1308
Coleman, 1999, PET in lung cancer, J. Nucl. Med., 40, 814
Sokoloff, 1977, The (14C)-deoxyglucose method for measurement of local cerebral glucose utilisation: theory, procedure and normal values in the conscious and anaesthetised albino rat, J. Neurochem., 28, 897, 10.1111/j.1471-4159.1977.tb10649.x
Phelps, 1979, Tomographic measurement of local cerebral glucose metabolic rate in humans with [18F]-fluoro-2-deoxy-d-glucose, Ann. Neurol., 6, 371, 10.1002/ana.410060502
Hawkins, 1986, Effects of temporal sampling, glucose metabolic rates and disruption of the blood–brain barrier on the FDG model with and without a vascular compartment: studies in human brain tumours with PET, J. Cereb. Blood Flow Metab., 6, 170, 10.1038/jcbfm.1986.30
Patlak, 1983, Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data, J. Cereb. Blood Flow Metab., 3, 1, 10.1038/jcbfm.1983.1
Herholz, 1987, The influence of tissue heterogeneity on results of fitting non-linear model equations to regional tracer uptake curves, J. Cereb. Blood Flow Metab., 7, 214, 10.1038/jcbfm.1987.47
Schmidt, 1996, Fluorine-18-fluorodeoxyglucose PET to determine regional cerebral glucose utilisation, J. Nucl. Med., 37, 394
Lammertsma, 1987, Measurement of glucose utilisation with [18F]-fluoro-2-deoxy-d-glucose, J. Cereb. Blood Flow Metab., 7, 161, 10.1038/jcbfm.1987.39
Spence, 1998, Glucose metabolism in human malignant gliomas measured quantitatively with PET, 1-[C-11]glucose and FDG, J. Nucl. Med., 39, 440
Minn, 1993, [18F]-fluorodeoxyglucose uptake in tumours, J. Comput. Assist. Tomogr., 17, 115, 10.1097/00004728-199301000-00021
Kole, 1997, Standardised uptake value and quantification of metabolism for breast cancer imaging with FDG and l-[11C]tyrosine PET, J. Nucl. Med., 38, 692
Avril, 1997, Breast imaging with fluorine-18-FDG PET, J. Nucl. Med., 38, 1186
Langen, 1993, The influence of plasma glucose levels on fluorine-18-fluorodeoxyglucose uptake in bronchial carcinomas, J. Nucl. Med., 34, 355
Lindholm, 1993, Influence of the blood glucose concentration on FDG uptake in cancer, a PET study, J. Nucl. Med., 34, 6
Ishizu, 1994, Effects of hyperglycemia on FDG uptake in human brain and glioma, J. Nucl. Med., 35, 1104
Zimny, 1997, Fluorine-18 fluorodeoxyglucose positron emission tomography in the differential diagnosis of pancreatic carcinoma, Eur. J. Nucl. Med., 24, 678
Fulham, 1995, Decreased cerebral glucose metabolism in patients with brain tumours, J. Neurosurg., 83, 657, 10.3171/jns.1995.83.4.0657
Roelcke, 1998, Dexamethasone treatment and plasma glucose levels, J. Nucl. Med., 39, 879
Langen, 1989, Early effects of intra-arterial chemotherapy in patients with brain tumours studied with PET, Nucl. Med. Commun., 10, 779, 10.1097/00006231-198911000-00002
Rozental, 1989, Glucose uptake by gliomas after treatment, Arch. Neurol., 46, 1302, 10.1001/archneur.1989.00520480044018
De Witte, 1994, Acute effect of carmustine on glucose metabolism in brain and glioblastoma, Cancer, 74, 2836, 10.1002/1097-0142(19941115)74:10<2836::AID-CNCR2820741015>3.0.CO;2-M
Ogawa, 1988, Changes of cerebral blood flow, and oxygen and glucose metabolism following radiochemotherapy of gliomas, J. Comp. Assist. Tomogr., 12, 290, 10.1097/00004728-198803000-00019
O'Reilly, 1995, Early changes in tumour glucose metabolism may predict and quantify response of gliomas to chemotherapy, Proc. Am. Soc. Clin. Oncol., 14, 499
Holthoff, 1993, In vivo metabolism of childhood posterior fossa tumours and primitive neuroectodermal tumours before and after treatment, Cancer, 72, 1394, 10.1002/1097-0142(19930815)72:4<1394::AID-CNCR2820720440>3.0.CO;2-D
Haberkorn, 1993, Fluorodeoxyglucose imaging of advanced head and neck cancer after chemotherapy, J. Nucl. Med., 34, 12
Jansson, 1995, Positron emission tomography studies in patients with locally advanced and/or metastatic breast cancer, J. Clin. Oncol., 13, 1470, 10.1200/JCO.1995.13.6.1470
Findlay, 1996, Noninvasive monitoring of tumour metabolism using fluorodeoxyglucose and positron emission tomography in colorectal cancer liver metastases, J. Clin. Oncol., 14, 700, 10.1200/JCO.1996.14.3.700
Hoekstra, 1993, Early treatment response in malignant lymphoma, as determined by planar fluorine-18-fluorodeoxyglucose scintigraphy, J. Nucl. Med., 34, 1706
Rigo, 1996, Oncological applications of positron emission tomography with fluorine-18-fluorodeoxyglucose, Eur. J. Nucl. Med., 23, 1641, 10.1007/BF01249629
Wilson, 1995, Imaging metastatic testicular germ cell tumours with 18F-FDG positron emission tomography, Eur. J. Nucl. Med., 22, 508, 10.1007/BF00817273
Van Ginkel, 1996, FDG-PET to evaluate response to hyperthermic isolated limb perfusion for locally advanced of soft tissue sarcoma, J. Nucl. Med., 37, 984
Haberkorn, 1991, PET studies of fluorodeoxyglucose metabolism in patients with recurrent colorectal tumours receiving radiotherapy, J. Nucl. Med., 32, 1485
Rozental, 1991, Early changes in tumour metabolism after treatment, Int. J. Radiat. Oncol. Biol. Phys., 20, 1053, 10.1016/0360-3016(91)90204-H
Minn, 1988, Evaluation of treatment response to radiotherapy in head and neck cancer with fluorine-18-fluorodeoxyglucose, J. Nucl. Med., 29, 1521
Cremerius, 1998, FDG PET for detection and therapy control of metastatic germ cell tumour, J. Nucl. Med., 39, 815
Brock CS, Young H, O'Reilly SM, et al. Early prediction of response in phase II study using [18F] fluorodeoxyglucose and positron emission tomography: experience with temozolomide and recurrent high grade astrocytomas. Br J Cancer 1999, in press.